Corporate News     03-Nov-22
Alembic Pharmaceuticals receives USFDA approval for Ketorolac Tromethamine Injection
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ketorolac Tromethamine Injection USP, 15 mg/mL, 30 mg/mL, and 60 mg/2 mL (30 mg/mL) Single Dose Vials.

This is the second injectable product approval from the company's General Sterile Facility (F-3) which was inspected in August, 2022

Previous News
  Volumes soar at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 02-Jan-24   14:30 )
  Alembic Pharmaceuticals receives USFDA approval for Dabigatran Etexilate Capsules
 ( Corporate News - 18-Jun-24   18:52 )
  Alembic Pharma gets USFDA nod for stroke and blood clots drug
 ( Hot Pursuit - 18-Jun-24   14:27 )
  Volumes soar at Lemon Tree Hotels Ltd counter
 ( Hot Pursuit - 02-Jan-24   11:00 )
  Alembic Pharmaceuticals receives USFDA approval for Docetaxel Injection
 ( Corporate News - 01-Mar-23   15:51 )
  Alembic Pharma jumps on USFDA nod for glaucoma drug
 ( Hot Pursuit - 31-Mar-23   10:10 )
  Alembic Pharma gets USFDA nod for hypertension drug
 ( Hot Pursuit - 30-Mar-23   14:08 )
  Alembic Pharma gets USFDA nod for Docetaxel injection
 ( Hot Pursuit - 01-Mar-23   11:59 )
  Alembic Pharma Bioequivalence facility completes USFDA inspection with no observations
 ( Hot Pursuit - 25-Oct-22   11:01 )
  Alembic Pharma receives PAS approval for its sANDA Pregabalin Capsules
 ( Corporate News - 22-Dec-22   13:53 )
  Alembic Pharmaceuticals to table results
 ( Corporate News - 01-Nov-22   12:10 )
Other Stories
  Lesha Industries to convene board meeting
  29-Jun-24   17:39
  Elecon Engineering Company to conduct board meeting
  29-Jun-24   17:39
  Mahamaya Steel Industries schedules AGM
  29-Jun-24   17:38
  Vivimed Labs to hold board meeting
  29-Jun-24   17:38
  3C IT Solutions and Telecoms (India) to hold board meeting
  29-Jun-24   17:38
  Purple Finance to consider fund raising
  29-Jun-24   17:38
  UGRO Capital to discuss results
  29-Jun-24   17:38
  Vivanza Biosciences to hold board meeting
  29-Jun-24   17:37
  Samrat Pharmachem to declare Quarterly Result
  29-Jun-24   17:37
  VL E-Governance & IT Solutions announces board meeting date
  29-Jun-24   17:37
Back Top